IMVT position history
The shares of Immunovant (IMVT) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q3: 22,500 shares, $864K, 0.27% of portfolio, New
- 2023 Q4: 40,742 shares, $1.7M, 0.41% of portfolio, Add +81.1%
- 2024 Q1: 29,416 shares, $950K, 0.22% of portfolio, Reduce −27.8%
- 2024 Q2: 47,916 shares, $1.3M, 0.30% of portfolio, Add +62.9%
- 2024 Q3: 51,996 shares, $1.5M, 0.35% of portfolio, Add +8.5%
- 2024 Q4: 107,996 shares, $2.7M, 0.68% of portfolio, Add +107.7%
- 2025 Q1: 169,996 shares, $2.9M, 0.82% of portfolio, Add +57.4%
- 2025 Q2: 191,493 shares, $3.1M, 0.85% of portfolio, Add +12.6%
- 2025 Q3: 191,493 shares, $3.1M, 0.76% of portfolio
- 2025 Q4: 150,524 shares, $3.8M, 0.89% of portfolio, Reduce −21.4%
- 2026 Q1: 150,524 shares, $3.7M, 0.85% of portfolio
- 2026 Q2: 149,524 shares, $5.8M, 1.1% of portfolio, Reduce −0.7%
- 2026 Q3: 135,524 shares, $4.6M, 0.98% of portfolio, Reduce −9.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|